Ethr from mycobacterium tuberculosis in complex with compound bdm31379 Deposition Author(s): Baulard, A. , Brodin, P. , Carette, X. , Christophe, T. , Demirkaya, F. , Deprez, B. , Desroses, M. , Dirie, B. , Flipo, M. , Jeon, H.K. , Lens, Z. , Leroux, F. , Locht, C. , Piveteau, C. , Rucktooa, P. , Villeret, V. , Willand, N.
Date: 2010-12-16 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3Q0U_A
Ethr from mycobacterium tuberculosis in complex with compound bdm31369 Deposition Author(s): Baulard, A. , Brodin, P. , Carette, X. , Christophe, T. , Demirkaya, F. , Deprez, B. , Desroses, M. , Dirie, B. , Flipo, M. , Jeon, H.K. , Lens, Z. , Leroux, F. , Leroux, F. , Locht, C. , Piveteau, C. , Rucktooa, P. , Villeret, V. , Willand, N.
Date: 2010-12-16 Method: X-RAY DIFFRACTION Resolution: 1.95 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3Q0V_A , 3Q0V_B
Ethr from mycobacterium tuberculosis in complex with compound bdm33066 Deposition Author(s): Baulard, A. , Brodin, P. , Carette, X. , Christophe, T. , Demirkaya, F. , Deprez, B. , Desrose, M. , Dirie, B. , Flipo, M. , Jeon, H.K. , Lens, Z. , Leroux, F. , Locht, C. , Piveteau, C. , Rucktooa, P. , Villeret, V. , Willand, N.
Date: 2010-12-16 Method: X-RAY DIFFRACTION Resolution: 1.6 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3Q0W_A
Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors. Deposition Author(s): Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Date: 2011-06-09 Method: X-RAY DIFFRACTION Resolution: 1.87 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3SDG_A
Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors. Deposition Author(s): Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Date: 2011-06-13 Method: X-RAY DIFFRACTION Resolution: 2.31 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3SFI_A
Novel n-phenyl-phenoxyacetamide derivatives as potential ethr inhibitors and ethionamide boosters. discovery and optimization using high-throughput synthesis. Deposition Author(s): Baulard, A.R. , Brodin, P. , Christophe, T. , Deprez, B. , Desroses, M. , Flipo, M. , Hounsou, C. , Jeon, H.K. , Lecat-Guillet, N. , Lens, Z. , Leroux, F. , Locht, C. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Date: 2012-02-24 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 4DW6_A
Triazolopyridine compounds as selective jak1 inhibitors: from hit identification to glpg0634 Deposition Author(s): Blanc, J. , Brys, R. , Christophe, T. , Ciesielski, F. , Clement-Lacroix, P. , Fletcher, S. , Galien, R. , Geney, R. , Jouannigot, N. , Lepescheux, L. , Menet, C.C.J. , Nelles, L. , Smits, K. , Uhring, M. , Van Der Aar, E.M. , Van Lommen, G. , Van Rompaey, L. , Vayssiere, B.
Date: 2014-03-27 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Homo Sapiens Sequences Data: 4P7E_A , 4P7E_B